Announcement on Implementation Result of Shares Repurchase and Share Changes
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation Result of Shares Repurchase and Share Changes
Filed with SSE · · 3 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-implementation-result-of-shares-repurchase-and-share-changes-174
Release
Chongqing Genrix Biopharmaceutical Co., Ltd. on 6ix
Earlier from Chongqing Genrix Biopharmaceutical
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Silevimig Injection
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of GR1803 Injection Combined with Anti-CD38 Monoclonal Antibody for Indications of Adult Patients with Relapsed/Refractory Multiple Myeloma
- Announcement on Progress in Repurchasing Shares
- Announcement on Resolutions of the 2024 Annual General Meeting
- Announcement on Initial Public Offering of Restricted Shares under Strategic Allotment for Circulation
Later from Chongqing Genrix Biopharmaceutical
- Announcement on Resignation of Senior Management Member and Adjustment of Core Technical Personnel
- Announcement on Voluntary Disclosure of Initiation of Phase 3 Clinical Trial of GR1802 for Indications for Allergic Rhinitis Treatment
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of GR1802 Injection Indicated for Adolescent Seasonal Allergic Rhinitis
- Announcement on Resolutions of the 3rd Meeting of the 2nd Board of Supervisors
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of GR2303 Injection
Follow Chongqing Genrix Biopharmaceutical into a list and get an email when it puts out news.
Follow Chongqing Genrix Biopharmaceutical